{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"1"},{"groupId":"OG008","value":"0"},{"groupId":"OG009","value":"0"},{"groupId":"OG010","value":"0"},{"groupId":"OG011","value":"0"},{"groupId":"OG012","value":"0"},{"groupId":"OG013","value":"0"},{"groupId":"OG014","value":"0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"2"},{"groupId":"OG005","value":"3"},{"groupId":"OG006","value":"4"},{"groupId":"OG007","value":"5"},{"groupId":"OG008","value":"6"},{"groupId":"OG009","value":"4"},{"groupId":"OG010","value":"4"},{"groupId":"OG011","value":"2"},{"groupId":"OG012","value":"4"},{"groupId":"OG013","value":"6"},{"groupId":"OG014","value":"3"}],"units":"Participants"}],"description":"Objective response rate per immune response evaluation criteria in solid tumors (iRECIST) for solid tumors","groups":[{"description":"0.0001 mg/kg of IV SL-279252 (Schedule 1)","id":"OG000","title":"SL-279252 (0.0001 mg/kg S1)"},{"description":"0.001 mg/kg of IV SL-279252 (Schedule 1)","id":"OG001","title":"SL-279252 (0.001 mg/kg S1)"},{"description":"0.003 mg/kg of IV SL-279252 (Schedule 1)","id":"OG002","title":"SL-279252 (0.003 mg/kg S1)"},{"description":"0.01 mg/kg of IV SL-279252 (Schedule 1)","id":"OG003","title":"SL-279252 (0.01 mg/kg S1)"},{"description":"0.03 mg/kg of IV SL-279252 (Schedule 1)","id":"OG004","title":"SL-279252 (0.03 mg/kg S1)"},{"description":"0.1 mg/kg of IV SL-279252 (Schedule 1)","id":"OG005","title":"SL-279252 (0.1 mg/kg S1)"},{"description":"0.3 mg/kg of IV SL-279252 (Schedule 1)","id":"OG006","title":"SL-279252 (0.3 mg/kg S1)"},{"description":"1.0 mg/kg of IV SL-279252 (Schedule 1)","id":"OG007","title":"SL-279252 (1.0 mg/kg S1)"},{"description":"3.0 mg/kg of IV SL-279252 (Schedule 1)","id":"OG008","title":"SL-279252 (3.0 mg/kg S1)"},{"description":"6.0 mg/kg of IV SL-279252 (Schedule 1)","id":"OG009","title":"SL-279252 (6.0 mg/kg S1)"},{"description":"12.0 mg/kg of IV SL-279252 (Schedule 1)","id":"OG010","title":"SL-279252 (12.0 mg/kg S1)"},{"description":"24.0 mg/kg of IV SL-279252 (Schedule 1)","id":"OG011","title":"SL-279252 (24.0 mg/kg S1)"},{"description":"0.3 mg/kg of IV SL-279252 (Schedule 2)","id":"OG012","title":"SL-279252 (0.3 mg/kg S2)"},{"description":"1.0 mg/kg of IV SL-279252 (Schedule 2)","id":"OG013","title":"SL-279252 (1.0 mg/kg S2)"},{"description":"3.0 mg/kg of IV SL-279252 (Schedule 2)","id":"OG014","title":"SL-279252 (3.0 mg/kg S2)"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"All treated population with solid tumors","reportingStatus":"POSTED","timeFrame":"Approximately 32 months","title":"Overall Response Rate of SL-279252","type":"SECONDARY","unitOfMeasure":"Participants"}